Aparna Parikh, MD, MS, Discusses Balancing Physical Fitness, Family Life, and Her Work in the GI Space

Video

Aparna Parikh, MD, MS, discusses how her early experiences with physical fitness shaped her current relationship with exercise.

Aparna Parikh's passion for fitness started early on with a love for competitive tennis in high school and college. Throughout her time in premed, Parikh continued to stay active, but it was a move to the San Francisco Bay area during her fellowship that gave her an appreciation of the great outdoors. She began biking to work and even swimming in the San Francisco Bay, leading into her first triathlon, which she completed while pregnant with her first child. In addition to discussing her passion for being physically active, she describes how she balances remaining active with saving lives at the Mass General Cancer Center in Boston, Massachusetts, and spending time with her family.

Recent Videos
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
The Together for Supportive Cancer Care coalition may advance the national conversation in ensuring comprehensive care for all patients with cancer.
Health care organizations have come together to form the Together for Supportive Cancer Care coalition to address gaps in supportive cancer care services.
Further optimizing a PROTAC that targets MDM2 may lead to human clinical trials among patients with cancer harboring p53 mutations.
Subsequent testing among patients in a prospective study may affirm the ability of cfDNA sequencing to detect cancers in those with Li-Fraumeni syndrome.
cfDNA sequencing may allow for more accessible, frequent, and sensitive testing compared with standard surveillance in Li-Fraumeni syndrome.
STX-478 showed efficacy in patients with advanced solid tumors regardless of whether they had kinase domain or helical PI3K mutations.